Pericarditis/Myopericarditis/Pericardial Effusion: A Contemporary Approach to Diagnosis and Management.

Publication date: Jul 17, 2026

Pericarditis is a common disease caused by various factors such as viral infections, systemic diseases, or drugs. A diagnosis of pericarditis is rendered in up to 5% of Emergency Room (ER) visits for non-ischemic chest pain. It is diagnosed when pleuritic chest pain is present, accentuated in the supine position, accompanied by ECG changes comprising new extensive ST-segment elevation and PR depression, a pericardial friction rub, and new or increased pericardial effusion on echocardiography. In North America and Western Europe, the most common causes of acute pericarditis are idiopathic or viral, followed by post-procedural (iatrogenic) pericarditis, radiation therapy, and cardiac surgery. Tuberculosis is the most common cause of pericarditis in endemic areas and is managed with antituberculosis therapy, with corticosteroids used when there is concurrent constrictive pericarditis. New diagnostic techniques have aided the sampling and analysis of pericardial fluid and in determining its cause. Treatment of pericarditis comprises high-dose Non-Steroidal AntiInflammatory Drugs (NSAIDs) for uncomplicated cases, with doses tapered when symptoms have subsided and C-reactive protein level has normalized, typically over several weeks. Colchicine (often a 3-6-month course) is needed to both alleviate symptoms and decrease recurrences, while glucocorticoids and newer therapies with interleukin-1 blockers are reserved for recurrences and/or failures of prior therapies. Integrated use of new imaging methods facilitates more precise detection and better management of complications such as pericardial effusion or constriction. The diagnostic yield of extensive laboratory evaluation and pericardiocentesis remains low; hence, invasive procedures should be limited mostly to patients in whom a therapeutic intervention is needed. The majority of pericardial effusions can be safely drained with an echo-guided percutaneous technique. Pericardiectomy remains the definitive treatment for constrictive pericarditis and provides symptomatic relief in most cases. Importantly, differentiation of constrictive pericarditis from restrictive cardiomyopathy remains a clinical challenge, but is facilitated by tissue Doppler and colour M-mode echocardiography. All these issues are reviewed herein.

Concepts Keywords
anti-inflammatory agents
cardiac tamponade
chest pain
colchicine
collagen vascular disease
constrictive pericarditis
corticosteroids
echocardiography
electrocardiographic changes
hemopericardium
non-ischemic chest pain
non-steroidal antiinflammatory agent
pericardial effusion
pericardiectomy
pericardiocentesis
Pericarditis
pleuritic chest pain
restrictive cardiomyopathy
tuberculosis
viral disease

Semantics

Type Source Name
disease MESH Pericarditis
disease MESH Pericardial Effusion
disease MESH viral infections
disease MESH Emergency
disease MESH chest pain
disease MESH Tuberculosis
pathway KEGG Tuberculosis
disease MESH constrictive pericarditis
drug DRUGBANK Colchicine
disease MESH recurrences
drug DRUGBANK Tropicamide
disease MESH restrictive cardiomyopathy
disease MESH cardiac tamponade
disease MESH vascular disease

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *